These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 30797240)

  • 1. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
    Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
    Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
    Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
    Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
    Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
    Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.
    Iaccarino L; Marelli S; Iannaccone S; Magnani G; Ferini-Strambi L; Perani D
    J Alzheimers Dis; 2016 Apr; 52(3):989-97. PubMed ID: 27060952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
    Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
    Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A follow up study of non-demented patients with primary visual cortical hypometabolism: prodromal dementia with Lewy bodies.
    Fujishiro H; Iseki E; Kasanuki K; Chiba Y; Ota K; Murayama N; Sato K
    J Neurol Sci; 2013 Nov; 334(1-2):48-54. PubMed ID: 23927939
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Whitwell JL; Graff-Radford J; Singh TD; Drubach DA; Senjem ML; Spychalla AJ; Tosakulwong N; Lowe VJ; Josephs KA
    J Nucl Med; 2017 Apr; 58(4):632-638. PubMed ID: 27688479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions.
    Fujishiro H; Iseki E; Kasanuki K; Murayama N; Ota K; Suzuki M; Sato K
    Int J Geriatr Psychiatry; 2012 Nov; 27(11):1138-46. PubMed ID: 22250011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The brain metabolic signature of visual hallucinations in dementia with Lewy bodies.
    Iaccarino L; Sala A; Caminiti SP; Santangelo R; Iannaccone S; Magnani G; Perani D
    Cortex; 2018 Nov; 108():13-24. PubMed ID: 30098477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating 2-[
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
    Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
    Lee YH; Jeon S; Yoo HS; Chung SJ; Jung JH; Baik K; Sohn YH; Lee PH; Yun M; Evans AC; Ye BS
    J Alzheimers Dis; 2021; 79(4):1471-1487. PubMed ID: 33459638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
    J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
    Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain
    Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
    J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Silva-Rodríguez J; Labrador-Espinosa MA; Moscoso A; Schöll M; Mir P; Grothe MJ;
    Brain; 2023 Nov; 146(11):4520-4531. PubMed ID: 37284793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.